A new Northwestern Medicine study suggests that a protein called Bim may be a novel therapeutic target for lupus.
Research published in Proceedings of the National Academy of Sciences provides new insights into antibodies that block the Epstein-Barr virus from infecting human cells.
A Northwestern Medicine study analyzing the genomes of more than 27,000 individuals has uncovered that ethnic disparities in lupus diagnoses have a genetic basis.
A protein called POP2 inhibits a key inflammatory pathway, calming the body’s inflammatory response before it can become destructive, Northwestern Medicine scientists have found.
A cancer drug for certain types of leukemia and lymphoma can also prevent reactions to some of the most common airborne allergies, according to a recent Northwestern Medicine study.
Targeting a molecule called B7-H4 may lead to the development of new therapies that boost the immune system’s ability to fight cancer, according to a review published in the journal Immunological Reviews.
Northwestern and Stanford scientists have uncovered new details on the structure of herpesviruses that allow them to initiate a fusion event to infect host cells.
Northwestern University synthetic biologists have developed a general method for “rewiring” immune cells to help overcome immunosuppression in cancer.
A Northwestern Medicine study, led by a fifth-year PhD student, has demonstrated that a cytokine known to be important in allergic disease called interleukin-33 (IL-33) plays a key role regulating stem cells under normal, healthy conditions.
Northwestern Medicine scientists continue to demonstrate that a protein called Hrd1 may be an important target for treating autoimmune diseases.